Drug insight: the role of albumin in the management of chronic liver disease (Q34597754)

3 August 2017

1 reference

title

Drug insight: the role of albumin in the management of chronic liver disease (English)

1 reference

3 August 2017

main subject

chronic liver disease

0 references

author name string

Florence Wong

series ordinal

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Nature Reviews Gastroenterology & Hepatology

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

43-51

1 reference

Human albumin administration in critically ill patients: systematic review of randomised controlled trials

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin--an important extracellular antioxidant?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Studies of I-131-albumin catabolism and distribution in normal young male adults

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Quantitative interrelationship between Gibbs-Donnan equilibrium, osmolality of body fluid compartments, and plasma water sodium concentration.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

The extraordinary ligand binding properties of human serum albumin

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Structural basis of the drug-binding specificity of human serum albumin

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Antioxidant properties of albumin: effect on oxidative metabolism of human neutrophil granulocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin: biochemical properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Effects of albumin supplementation on microvascular permeability in septic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin therapy in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

A comparison of albumin and saline for fluid resuscitation in the intensive care unit

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Parvoviruses and blood products

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Management of adult patients with ascites due to cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Intravenous Albumin in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Intravenous albumin reduces mortality in patients with spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis: is it worth the cost?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Albumin infusion for spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

1 reference

7 January 2021

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0680

1 reference

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0680

1 reference

3 August 2017

1 reference